Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOM trial: combined hormonal contraceptives to prevent abnormal vaginal bleeding with 3‑year contraceptive implant
TCTR20250725003Phase 4Completed
- Sponsor
- Nakornping Hospital
- Start
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in menstrual disorders (3 arms), sponsored by Nakornping Hospital. Primary endpoint: Incidence of abnormal vaginal bleeding. Started Jan 2025; status: completed.
02
Conditions
menstrual disorders
Beyond the preview
Go deeper on TCTR20250725003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250725003.